CD44 and esophageal squamous cell carcinoma: In both hepatocellular carcinoma (40) and esophageal squamous cell carcinoma (ESCC) (41), CellPhoneDB implicated the SPP1-CD44 signaling axis, among other receptor-ligand pairs, as a potential reprogramming interaction from tumor cells to macrophages.